About Us





Peter Leeming, BSc, PhD
Director of Process Research and Development; Norac Pharma


Peter Leeming is the Director of Process Research and Development at Norac Pharma. He leads the process research and development activities at Norac Pharma concluding with new product manufacturing for both contract pharma and “in-house” active pharmaceutical ingredient (API) projects. Peter has accumulated around 19 years of industrial process R&D and manufacturing experience in both the fine chemical and pharmaceutical industries working initially for NSC Technologies (a division of Monsanto NutraSweet) followed by Great Lakes Fine Chemicals Division and Albany Molecular Research (AMRI) before joining Norac Pharma in 2008. Peter’s academic qualifications comprise 1st class honors degree in Applied Chemistry with professional experience and a PhD degree from the University of Salford in the United Kingdom with subsequent Postdoctoral research studies under Professor A. R. Katritzky at the University of Florida and then Professor T. C. Gallagher at the University of Bristol. Peter brings to Norac Pharma a sound scientific and scale-up background from both the fine chemical and pharmaceutical industries along with a solid comprehension of cGMP requirements for successful scale-up and manufacture at metric ton scale. Peter’s responsibilities at Norac Pharma include assisting his staff in defining robust and safely scalable processes for supplying API’s across all phases of pharmaceutical development, from discovery through preclinical, clinical trials, through process validation and commercialization. Peter has also been involved in DMF submissions for numerous API’s being developed by Norac Pharma as well as assisting clients in filing IND’s in early phase API process development activities.